Intramammary containing cloxacillin, used to treat Staph. aureus mastitis in dairy cows
Nitroclox™ LA is an intramammary mastitis treatment for lactating dairy cows that contains cloxacillin. It is a Staph. aureus specialist and is used for treatment in mid to late lactation.
The entire contents of one syringe should be infused into the teat canal of each infected quarter immediately following milking. Repeat the treatment twice more at either 24 or 48 hour intervals - three syringes provide a full course of treatment. If required, an extended treatment of 6 syringes at 24 hour intervals may be given.
It is an offence for users of this product to cause residues exceeding the relevant MRL in the Food Notice: Maximum Residue Levels for Agricultural Compounds.
Available in boxes of 21 syringes.
This product is classified as orange under Antibiotic Judicious Use Guidelines for the New Zealand Veterinary Profession. Orange light antimicrobials are restricted to specific indications or used as second line therapy under therapeutic conditions. Visit nzva.org.nz/amr and talk to your Vet to learn more. Please use antibiotics responsibly.
To learn more about Nitroclox™ LA, download the Product Profile below and talk to your Vet. To learn more about mastitis, visit the mastitis page in our Health Care section.
Nitroclox™ LA is a Restricted Veterinary Medicine. Available only under Veterinary Authorisation. Registered pursuant to the ACVM Act 1997, No. A10279.
Orbenin® LA is a registered trademark of GSK NZ Ltd. Restricted Veterinary Medicine. Available only under Veterinary Authorisation. Registered pursuant to the ACVM Act 1997, No. A3664.